Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults With Congenital Heart Disease
CJC Pediatr Congenit Heart Dis
.
2024 Feb 17;3(3):115-116.
doi: 10.1016/j.cjcpc.2024.02.001.
eCollection 2024 Jun.
Authors
Snigdha Karnakoti
1
,
Kartik Andi
1
,
William R Miranda
1
,
C Charles Jain
1
,
Luke J Burchill
1
,
Maan Jokhadar
1
,
Heidi M Connolly
1
,
Alexander C Egbe
1
Affiliation
1
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA.
PMID:
39070958
PMCID:
PMC11282876
DOI:
10.1016/j.cjcpc.2024.02.001
No abstract available